Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Cancer Med ; 12(8): 9293-9302, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-36779618

RESUMEN

BACKGROUND: The north and north-eastern regions of India have among the highest incidence of gallbladder cancer (GBC) in the world. We report the clinicopathological charateristics and outcome of GBC patients in India. METHODS: Electronic medical records of patients diagnosed with GBC at Tata Medical Center, Kolkata between 2017 and 2019 were analyzed. RESULTS: There were 698 cases of confirmed GBC with a median age of 58 (IQR: 50-65) years and female:male ratio of 1.96. At presentation, 91% (496/544) had stage III/IV disease and 30% (189/640) had incidental GBC. The 2-year overall survival (OS) was 100% (95% CI: 100-100); 61% (95% CI: 45-83); 30% (95% CI: 21-43); and 9% (95% CI: 6-13) for stages I-IV, respectively (p = <0.0001).   For all patients, the 2-year OS in patients who had a radical cholecystectomy followed by adjuvant therapy (N = 36) was 50% (95% CI: 39-64), compared to 29% (95% CI: 22-38) for those who had a simple cholecystectomy and/or chemotherapy (N = 265) and 9% (95% CI: 6-14) in patients who were palliated (N = 107) (p = <0.0001). CONCLUSION: The combined surgical/chemotherapy approach for patients with stage II GBC showed the best outcomes. Early detection of GBC remains problematic with the majority of patients presenting with stage III-IV and who have a median survival of 9.1 months. Our data suggests that the tumor is chemoresponsive and multi-center collaborative clinical trials to identify alternative therapies are urgently required.


Asunto(s)
Carcinoma in Situ , Neoplasias de la Vesícula Biliar , Humanos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Neoplasias de la Vesícula Biliar/diagnóstico , Neoplasias de la Vesícula Biliar/epidemiología , Neoplasias de la Vesícula Biliar/terapia , Colecistectomía , Terapia Combinada , Carcinoma in Situ/patología , Hospitales , Estadificación de Neoplasias , Estudios Retrospectivos
2.
Mater Sci Eng C Mater Biol Appl ; 117: 111304, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32919665

RESUMEN

The present work highlights biosynthesis of nano-sized heterometalic spinel ZnCo2O4 particles using different green extracts as capping agent. In this work we have fabricated polygonal ZnCo2O4 with Punica granatum peel extract, Camellia sinensis extract, Moringa oleifera leaf extract and green coffee beans extract in an effortless green pathway. Phase pure material synthesis was confirmed using XRD. Microstructural, morphological, compositional and optical characterisations has been carried out using TEM, FESEM, EDX, FTIR, photoluminescence and UV-Vis spectroscopy. Punica granatum peel extract assisted ZnCo2O4 sample shows superior catalytic efficiency of ~84.96% for Rhodamine B pollutant. ZnCo2O4 sample synthesized using pomegranate peel extract shows highest conductivity of ~8.074 × 10-5 Ω-1 cm-1 with activation energy of 2.099 eV at 503 K. Synthesized nanoparticles also show antibacterial activity for B. megaterium, B. subtilis and B. cereus. To the best of our knowledge, synthesis of ZnCo2O4 using these four green extracts and their comparative degradation capability, electrical properties and antibacterial study is explained for the first time in this work.


Asunto(s)
Tecnología Química Verde , Nanopartículas del Metal , Óxido de Aluminio , Óxido de Magnesio , Extractos Vegetales
3.
J Surg Oncol ; 105(2): 130-4, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21842520

RESUMEN

BACKGROUND: Pathological staging and regression grading may affect the clinical outcome in rectal carcinoma patients treated with neoadjuvant chemoradiation (NACRT). Oncocytic change (OC) has also been described in the residual tumor. This study assesses the correlation of degree of pathological response and OC with clinical outcome. METHODS: Seventy-five cases of rectal adenocarcinoma undergoing NACRT followed by surgery were retrospectively analyzed for preoperative and post-operative staging, degree of tumor response to NACRT using the Dworak Regression score (DR) and Tumor Regression Grading (TRG) systems, as well as the proportion of cells showing OC. These parameters were correlated with overall survival (OS) and disease-free survival (DFS). RESULTS: Significant correlation was found between post-operative T and N stage and OS (P = 0.005 and 0.002, respectively); and post-operative and preoperative T stage with DFS (P = 0.002 and 0.02, respectively). Grouping patients by TRG scores (TRG1-3 vs TRG4-5) also proved to be a significant independent prognosticator for DFS (P < 0.001). The DR score groups and OC (<35% vs. >35%) were not statistically significant predictors of clinical outcome. CONCLUSIONS: Post-NACRT T and N staging and the TRG system are important prognostic indicators. The presence and extent of OC needs to be better understood and further investigated.


Asunto(s)
Adenocarcinoma/patología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Quimioradioterapia Adyuvante , Terapia Neoadyuvante , Neoplasia Residual/patología , Neoplasias del Recto/patología , Adenocarcinoma/mortalidad , Adenocarcinoma/terapia , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Fluorouracilo/administración & dosificación , Estudios de Seguimiento , Humanos , Leucovorina/administración & dosificación , Masculino , Persona de Mediana Edad , Mitomicina/administración & dosificación , Clasificación del Tumor , Estadificación de Neoplasias , Neoplasia Residual/mortalidad , Neoplasia Residual/terapia , Cuidados Posoperatorios , Neoplasias del Recto/mortalidad , Neoplasias del Recto/terapia , Estudios Retrospectivos , Tasa de Supervivencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA